Frier Levitt attorneys Daniel Frier, Theresa DiGuglielmo, and Nicole DeWitt published an article in Medical Economics titled, “The Importance of Mounting a Robust Response to Urine PCR Testing Denials and Clawbacks.” The piece delves into the increased utilization of advanced diagnostic tools, specifically, multiplex polymerase chain reaction (PCR) urine testing. While these tests improve patient outcomes with more precise and timely diagnoses, they also create challenges for providers when payers deny claims or demand recoupments for these urine PCR tests.
In the article, Daniel, Theresa and Nicole explore a recent case where Frier Levitt assisted a urology group in negotiating a resolution after their largest payer audited and sought nearly $500,000 in recoupments for urine PCR claims. Additionally, they discuss how proactive legal strategies can protect providers and support access to advanced diagnostic testing.
Read the article here: https://www.medicaleconomics.com/view/the-importance-of-mounting-a-robust-response-to-urine-pcr-testing-denials-and-clawbacks
